Novo Nordisk’s biggest battle may be internal, as it seeks to transform itself from a cautious drugmaker into a nimble consumer brand https://t.co/VfDUCTNWzV ...

Cyber Monday shopping? Drugmaker Eli Lilly & Co. is rolling out discounts of its own, slashing the cash-pay prices for starting doses of its wildly popular weight-loss shot https://t.co/DKngl3UhqW ...

CSL plunged to the lowest in almost seven years after Australia’s biggest drugmaker postponed plans to spin off its vaccines business, as falling US flu immunizations deepen concern over a slowdown in its Seqirus unit https://t.co/beNbf0JryF ...

Novo Nordisk found a new leader for its investor relations department in an equity analyst who has recommended buying shares in the drugmaker for almost 15 years https://t.co/8v8P1sB2iH ...

Denmark’s Genmab is in advanced talks to acquire Merus, a Dutch drugmaker that’s developing a treatment for cancer of the head and neck https://t.co/etZIWnnxC2 ...

Novo Nordisk said it is laying off about 11.5% of its workforce in a "transformation" of the drugmaker's business. https://t.co/pJUR4lhGVL ...

Bristol-Myers’ CEO is stepping down from his role after six years at the company, a surprise move as the drugmaker races to find its next hit https://t.co/RzMYh7aX68 ...

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million https://t.co/F8zYQF78xw ...

CapVest is in talks to acquire a majority stake in Stada Arzneimittel in a deal that could value the German drugmaker at about €10 billion ($11.7 billion) including debt https://t.co/mcTNczQt0h ...

Financial Performance - Abbott Laboratories shares slumped Thursday after narrowing its full-year outlook [1] - Abbott posted better-than-expected quarterly results [1] Market Dynamics - Demand for COVID-19 tests declines [1]